Lactation Outcomes Among Survivors of Pediatric Cancer
1 other identifier
observational
471
1 country
1
Brief Summary
While the majority of women in the general population can breastfeed successfully, the investigators have limited knowledge about the correlates and sequelae of lactation success among women treated for pediatric malignancies. Childhood cancer treatments are known to cause late effects that frequently involve the endocrine system. Because normal lactation is dependent upon interplay of multiple endocrine factors, the investigators anticipate more breastfeeding difficulties in survivors that have diabetes, growth hormone deficiencies, thyroid disorders and obesity. In order to more fully inform clinicians and female survivors, the study of the burden of lactation failure is needed to begin to address the impact of pediatric cancer therapy on lactation success/failure and to examine the association of specific endocrine disorders on lactation outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 23, 2015
CompletedFirst Posted
Study publicly available on registry
March 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 10, 2015
December 1, 2015
9 months
March 23, 2015
December 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Number of survivors who experience successful breastfeeding outcome by age at diagnosis
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by years since diagnosis
Years since diagnosis will equal the years since diagnosis prior to first pregnancy resulting in a live birth.
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by therapy with radiation
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by therapy with surgery
Includes chest and/or brain surgery.
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by diagnosis of growth hormone deficiency
Growth hormone deficiency indicated by low IGF-1
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by diagnosis of hypothyroidism
Hypothyroidism, primary or central, measured by TSH level.
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by diagnosis of diabetes mellitus
Once, at enrollment (Day 1)
Number of survivors who experience successful breastfeeding outcome by diagnosis of obesity
Obesity (BMI) prior to pregnancy.
Once, at enrollment (Day 1)
Secondary Outcomes (1)
Number of survivors who experience successful breastfeeding outcome compared to healthy women
Once, at enrollment (Day 1)
Study Arms (1)
Survivors
Participants will be recruited from the St. Jude Lifetime Cohort (SJLIFE protocol) and the After Completion of Therapy (ACT) Clinic at St. Jude Children's Research Hospital. Intervention: Survey
Interventions
Those who agree to participate will complete a cross-sectional survey on lactation outcomes (LACOUT). Eligible participants who consent to our study will complete the LACOUT questionnaire. The questionnaire uses the same breastfeeding measures as the CDC's Project First surveys and adds 21 items that are specific to the participant's cancer treatment and current health status.
Eligibility Criteria
Females who are childhood cancer survivors and have reported at least one live birth after cancer diagnosis and treatment.
You may qualify if:
- Participants in the SJLIFE protocol or patients in the After Completion of Therapy (ACT) Clinic, both at St. Jude Children's Research Hospital.
- Female
- years of age or older
- At least one reported live birth after childhood cancer diagnosis and treatment.
You may not qualify if:
- Unable to read and write.
- Unable to read and understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Publications (1)
Ogg S, Klosky JL, Chemaitilly W, Srivastava DK, Wang M, Carney G, Ojha R, Robison LL, Cox CL, Hudson MM. Breastfeeding practices among childhood cancer survivors. J Cancer Surviv. 2020 Aug;14(4):586-599. doi: 10.1007/s11764-020-00882-y. Epub 2020 Apr 14.
PMID: 32291564DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Cox, PhD
St. Jude Children's Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2015
First Posted
March 26, 2015
Study Start
March 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 10, 2015
Record last verified: 2015-12